2019
DOI: 10.1111/imj.14636
|View full text |Cite
|
Sign up to set email alerts
|

Tumour necrosis factor‐alpha inhibitor induced recurrent symptomatic hypoglycaemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…[ 36 ] The ART–daumone hybrid 15 (MTT assay) inhibited MDA‐MB‐231 and A549 cell invasion by 53% and 85% at the concentration of 2.5 µM. [ 37 ] In the MDA‐MB‐231‐ and A549‐xenografted mice models, hybrid 15 (20 mg/kg, oral administration) could suppress ~70% tumor growth without tissue damage in the liver and kidneys. Thus, hybrids 14 and 15 could serve as lead compounds for further investigations.…”
Section: Art Hybridsmentioning
confidence: 99%
“…[ 36 ] The ART–daumone hybrid 15 (MTT assay) inhibited MDA‐MB‐231 and A549 cell invasion by 53% and 85% at the concentration of 2.5 µM. [ 37 ] In the MDA‐MB‐231‐ and A549‐xenografted mice models, hybrid 15 (20 mg/kg, oral administration) could suppress ~70% tumor growth without tissue damage in the liver and kidneys. Thus, hybrids 14 and 15 could serve as lead compounds for further investigations.…”
Section: Art Hybridsmentioning
confidence: 99%